- Home
- SUPN vs LTC Comparison
SUPN vs LTC Comparison
Compare SUPN & LTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SUPN | LTC |
|---|---|---|
| Founded | 2005 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 1.7B |
| IPO Year | 2012 | 1992 |
Fundamental Metrics
Financial Performance| Metric | SUPN | LTC |
|---|---|---|
| Price | $47.22 | $34.77 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 5 |
| Target Price | ★ $63.25 | $39.00 |
| AVG Volume (30 Days) | ★ 639.4K | 382.5K |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 6.57% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.72 |
| Revenue | ★ $681,539,000.00 | $226,987,000.00 |
| Revenue This Year | $8.32 | N/A |
| Revenue Next Year | $23.36 | $22.49 |
| P/E Ratio | ★ N/A | $48.10 |
| Revenue Growth | 4.54 | ★ 14.23 |
| 52 Week Low | $29.16 | $31.70 |
| 52 Week High | $57.65 | $37.56 |
Technical Indicators
Market Signals| Indicator | SUPN | LTC |
|---|---|---|
| Relative Strength Index (RSI) | 53.47 | 39.34 |
| Support Level | $45.36 | $34.28 |
| Resistance Level | $47.26 | $35.68 |
| Average True Range (ATR) | 1.23 | 0.58 |
| MACD | 0.36 | -0.18 |
| Stochastic Oscillator | 92.10 | 19.09 |
Price Performance
Historical ComparisonAbout SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About LTC LTC Properties Inc.
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in seniors housing and healthcare facilities through mortgage loans, property lease transactions, and other investments. Its real estate investments includes different types of properties such as Independent living communities, Assisted living communities, Memory care communities, Skilled nursing centers and other types of properties.